Spectrum Pharmaceuticals Aktie

Kaufen

Verkaufen

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Bei einem anderen Broker handeln

WKN164623

ISINUS84763A1088

SymbolSPPI

Spectrum Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

08.09.25PR NewswireSPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025

19.08.25PR NewswireNASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action

06.08.25PR NewswireBerger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors

20.07.23BusinesswireIndependent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote "FOR” Proposed Transaction with Assertio Holdings, Inc.

03.07.23PR NewswireIMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, ASRT, MDWT, SPPI

17.05.23BusinesswireSpectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

09.05.23BusinesswireSpectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

22.03.23BusinesswireSpectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update

17.03.23BusinesswireSpectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

08.02.23BusinesswireSpectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services

31.01.23BusinesswireSpectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results

31.01.23PR NewswireSPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 3, 2023 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders

28.01.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI

26.01.23BusinesswireSpectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff

25.01.23PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)

24.01.23PR NewswireSPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 3, 2023 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders

20.01.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI

18.01.23PR NewswireROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action- SPPI

18.01.23PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)

16.01.23PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Spectrum Investors of a Lead Plaintiff Deadline of February 3, 2023

13.01.23PR NewswireSPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

12.01.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI

10.01.23PR NewswireSPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 3, 2023 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders

05.01.23PR NewswireSPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

04.01.23BusinesswireSpectrum Pharmaceuticals Announces Management Changes

04.01.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI

28.12.22PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)

27.12.22BusinesswireSpectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff

26.12.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI

15.12.22PR NewswireSPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

13.12.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI

12.12.22PR NewswireBronstein, Gewirtz & Grossman, LLC Notifies Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate

08.12.22PR NewswireSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

06.12.22BusinesswireSpectrum Pharmaceuticals’ ROLVEDON™ (eflapegrastim-xnst) Injection Added to NCCN Supportive Care Guidelines in Oncology for Hematopoietic Growth Factors

06.12.22PR NewswirePomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI

05.12.22BusinesswireSpectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff

25.11.22BusinesswireSpectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON™ (eflapegrastim-xnst) injection

10.11.22BusinesswireSpectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03.11.22BusinesswireSpectrum Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals News

Spectrum Pharmaceuticals News: auf dieser Seite finden Sie alle Spectrum Pharmaceuticals News und Nachrichten zur Spectrum Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Spectrum Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Spectrum Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.